Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.
Aliment Pharmacol Ther. 2022 Jul;56(2):310-320. doi: 10.1111/apt.16968. Epub 2022 May 6.
Aliment Pharmacol Ther. 2022.
PMID: 35521992
Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age.
Howell J, Anderson D, Bloom S, Lubel J, Kemp W, Williams J, Bell S, Croagh C, Demediuk B, Desmond P, Hall S, Holmes J, Hong T, Iser D, Lim L, Papaluca T, Ryan M, Visvanathan K, Xiao Y, van Gemert C, Hellard M, Thompson A.
Howell J, et al.
J Hepatol. 2020 Nov;73(5):1282-1284. doi: 10.1016/j.jhep.2020.06.031. Epub 2020 Sep 1.
J Hepatol. 2020.
PMID: 32888765
No abstract available.
Item in Clipboard
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways.
Hall SAL, Burns GS, Mooney BJ, Millen R, Morris R, Vogrin S, Sundararajan V, Ratnam D, Levy MT, Lubel JS, Nicoll AJ, Strasser SI, Sievert W, Desmond PV, Ngu MC, Angus P, Sinclair M, Meredith C, Matthews G, Revill PA, Jackson K, Littlejohn M, Bowden S, Locarnini SA, Thompson AJ, Visvanathan K.
Hall SAL, et al.
J Infect Dis. 2022 Dec 28;227(1):123-132. doi: 10.1093/infdis/jiac375.
J Infect Dis. 2022.
PMID: 36108079
Item in Clipboard
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants.
Thompson AJ, Jackson K, Bonanzinga S, Hall SAL, Hume S, Burns GS, Sundararajan V, Ratnam D, Levy MT, Lubel J, Nicoll AJ, Strasser SI, Sievert W, Desmond PV, Ngu MC, Sinclair M, Meredith C, Matthews G, Revill PA, Littlejohn M, Bowden DS, Canchola JA, Torres J, Siew P, Lau J, La Brot B, Kuchta A, Visvanathan K.
Thompson AJ, et al. Among authors: hall sal.
Hepatol Commun. 2023 Jul 17;7(8):e0188. doi: 10.1097/HC9.0000000000000188. eCollection 2023 Aug 1.
Hepatol Commun. 2023.
PMID: 37459199
Free PMC article.
Clinical Trial.
Item in Clipboard
Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis.
Hall SAL, Vogrin S, Wawryk O, Burns GS, Visvanathan K, Sundararajan V, Thompson A.
Hall SAL, et al.
Gut. 2022 Aug;71(8):1629-1641. doi: 10.1136/gutjnl-2020-323979. Epub 2021 Sep 7.
Gut. 2022.
PMID: 34493592
Item in Clipboard
Hepatitis B screening before rituximab therapy: a multicentre South Australian study of adherence.
Hall SAL, Shaikh A, Teh K, Tantiongco M, Coghlan D, Karapetis CS, Chinnaratha MA, Woodman R, Muller KR, Wigg AJ.
Hall SAL, et al.
Intern Med J. 2018 Aug;48(8):936-943. doi: 10.1111/imj.13740.
Intern Med J. 2018.
PMID: 29345413
Item in Clipboard
Cite
Cite